Market Overview:
The global oral mucositis therapeutics market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, rising demand for better treatment options, and growing awareness about oral mucositis. Based on type, the global oral mucositis therapeutics market can be segmented into chemotherapy-induced and radiotherapy-induced oral mucositis. Chemotherapy-induced oral mucositis is more common than radiotherapy-induced oral mucositis and is expected to account for a larger share of the global market in 2018. By application, the global Oral Mucositus Therapeutics Market can be divided into hospitals, dental clinics, and others (including research institutes). Hospitals are expected to account for a larger share of this market in 2018.
Product Definition:
Oral mucositis is a common complication of cancer treatments such as chemotherapy and radiation therapy. It is characterized by inflammation and ulceration of the mucous membranes lining the mouth and throat. Oral mucositis can cause pain, difficulty swallowing, and malnutrition. The severity of oral mucositis varies from person to person, but it can be a very debilitating condition.
Oral mucositis Therapeutics are drugs or other interventions that are used to treat oral mucositis. They may include pain medications, antibiotics, antifungals, or nutritional supplements. The goal of oral mucositis therapy is to reduce inflammation and pain, promote healing of the ulcers, and prevent infection.
Chemotherapy:
Chemotherapy is a medication used to treat cancer. The word itself originates from the Greek language “chemo” which means “chemical” and “theraphe” which means treatment. Chemotherapy is used for treating various types of cancers such as skin, lung, breast, ovarian and others by using drugs that interact with cancer cells (toxic).
Radiotherapy:
Radiotherapy is a treatment method that uses ionizing radiation to control and kill the cancerous cells. The most common types of cancers treated with radiotherapy include lung, breast, colorectal, esophageal, stomach and liver tumors. According to the American Cancer Society estimates in 2018; there will be an estimated 1.78 million new cases of cancer and 585 thousand deaths due to cancer in the U.
Application Insights:
Based on the application, the global market is segmented into hospitals, dental clinics and others. The hospitals segment dominated the overall market in terms of revenue in 2017 owing to a high prevalence of cancer and increasing awareness about OMM therapies. Furthermore, an increase in hospital-based OMM treatment due to technological advancements such as robot-assisted devices is expected to boost demand over the forecast period.
The dental clinics segment is anticipated to witness lucrative growth over the forecast period owing to rising incidences of oral cancer among patients aged 60 years or above at a significantly higher rate compared with other age groups across countries worldwide. Thus, this demographic group represents a key target population for regular checkups at dentists¢â‚¬â„¢ offices which may eventually lead them towards opting for medical checkups at dental care facilities followed by hospital visits if necessary which will ultimately drive demand over the forecast period.
The others application category includes surgical oncology centers.
Regional Analysis:
Europe dominated the global market in 2017. The presence of well-established healthcare facilities, favorable reimbursement policies, and availability of advanced treatment options are some factors responsible for its dominance. In addition, increasing prevalence of cancer is also expected to drive the regional market during the forecast period. For instance, as per statistics published by Eurostat in 2018; around 6% population aged 5-19 years old is suffering from cancer which is an increase from 4% population aged 5-9 years old suffering from same disease in 2015.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for oral mucositis therapeutics market. Oral mucositis is a common complication in patients receiving radiation therapy or chemotherapy for head and neck cancers. According to American Cancer Society, approximately 50,000 new cases of head and neck cancers are diagnosed in the U.S. each year. This number is expected to rise due to the aging population and increased tobacco use among women
- Rising demand for novel therapies: The rising demand for novel therapies is another key growth driver for oral mucositis therapeutics market. Oral mucositis often leads to debilitating pain, infection, and nutritional deficiencies that can significantly impact patient quality of life . Novel therapies such as amifostine offer potential relief from these symptoms
Scope Of The Report
Report Attributes
Report Details
Report Title
Oral Mucositis Therapeutics Market Research Report
By Type
Chemotherapy, Radiotherapy
By Application
Hospitals, Dental Clinics, Others
By Companies
M Healthcare, GSK, Pfizer, Colgate-Palmolive, Norgine, Biovitrum, Bausch Health, EUSA Pharma, Camurus, Mission Pharmacal, Clinigen Group, Midatech Pharma, Alliance Pharma, AMAG Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
124
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global Oral Mucositis Therapeutics Market Report Segments:
The global Oral Mucositis Therapeutics market is segmented on the basis of:
Types
Chemotherapy, Radiotherapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Dental Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- M Healthcare
- GSK
- Pfizer
- Colgate-Palmolive
- Norgine
- Biovitrum
- Bausch Health
- EUSA Pharma
- Camurus
- Mission Pharmacal
- Clinigen Group
- Midatech Pharma
- Alliance Pharma
- AMAG Pharmaceuticals
Highlights of The Oral Mucositis Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemotherapy
- Radiotherapy
- By Application:
- Hospitals
- Dental Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oral Mucositis Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oral mucositis therapeutics is a term used to describe medications and other treatments that are used to treat oral mucositis. Oral mucositis is a condition that can occur when the mouth becomes inflamed due to infection or another cause. The symptoms of oral mucositis can include pain, soreness, and swelling in the mouth. Some common treatments for oral mucositis include antibiotics, painkillers, and anti-inflammatory drugs.
Some of the major companies in the oral mucositis therapeutics market are M Healthcare, GSK, Pfizer, Colgate-Palmolive, Norgine, Biovitrum, Bausch Health, EUSA Pharma, Camurus, Mission Pharmacal, Clinigen Group, Midatech Pharma, Alliance Pharma, AMAG Pharmaceuticals.
The oral mucositis therapeutics market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Oral Mucositis Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Oral Mucositis Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Oral Mucositis Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Oral Mucositis Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Oral Mucositis Therapeutics Market Size & Forecast, 2020-2028
4.5.1 Oral Mucositis Therapeutics Market Size and Y-o-Y Growth
4.5.2 Oral Mucositis Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Chemotherapy
5.2.2 Radiotherapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Dental Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Oral Mucositis Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Oral Mucositis Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Chemotherapy
9.6.2 Radiotherapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Dental Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Chemotherapy
10.6.2 Radiotherapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Dental Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Chemotherapy
11.6.2 Radiotherapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Dental Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Chemotherapy
12.6.2 Radiotherapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Dental Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Chemotherapy
13.6.2 Radiotherapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Dental Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Oral Mucositis Therapeutics Market: Competitive Dashboard
14.2 Global Oral Mucositis Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 M Healthcare
14.3.2 GSK
14.3.3 Pfizer
14.3.4 Colgate-Palmolive
14.3.5 Norgine
14.3.6 Biovitrum
14.3.7 Bausch Health
14.3.8 EUSA Pharma
14.3.9 Camurus
14.3.10 Mission Pharmacal
14.3.11 Clinigen Group
14.3.12 Midatech Pharma
14.3.13 Alliance Pharma
14.3.14 AMAG Pharmaceuticals
